Reet International

PTH 30 Tablet (Cinacalcet)
PTH 30 Tablet contains Cinacalcet, a calcimimetic agent used primarily to treat conditions associated with elevated levels of parathyroid hormone (PTH), such as secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on dialysis. It is also used to manage hypercalcemia in patients with parathyroid carcinoma and primary hyperparathyroidism when surgery is not an option.
Cinacalcet works by increasing the sensitivity of calcium-sensing receptors in the parathyroid glands, which helps reduce the production of PTH. This leads to a decrease in calcium levels in the blood, effectively managing conditions of hypercalcemia and preventing bone-related complications caused by excessive PTH.
PTH 30 is typically taken once daily, with or just after food. The dosage may be adjusted based on blood tests that monitor calcium and PTH levels. It is crucial to follow the healthcare provider's dosing instructions carefully to achieve optimal results and avoid complications.
Common side effects of Cinacalcet include nausea, vomiting, muscle pain, and low calcium levels (hypocalcemia), which can lead to symptoms like tingling, muscle cramps, or spasms. Regular monitoring of calcium levels is necessary to prevent hypocalcemia, which, if severe, can cause more serious complications like heart arrhythmias or seizures.
Patients with conditions like low calcium levels, heart problems, or liver disease should use Cinacalcet with caution. It's important to inform your healthcare provider about all current medications to avoid potential interactions, especially with drugs affecting calcium or heart rhythms.
Overall, PTH 30 Tablet (Cinacalcet) is a vital treatment for managing calcium and PTH levels in patients with specific parathyroid disorders, helping prevent complications like bone disease and maintaining overall health. Regular follow-up and monitoring are essential for safe and effective use.